
What We're Reading: FDA Does a Poor Job Tracking Drugs on the Market
What we're reading, January 15, 2016: new report finds flaws in how the FDA tracks drugs after they reach the market; rate of uninsured Hispanic children hits historic low; and CVS and New York State make medication that reverses opioid overdose available without prescription.
A new report from the Government Accountability Office has found flaws in the way the FDA tracked drugs once they were on the market. Overall, the FDA was not doing a good job with following up with how the drug does in the marketplace with issues such as patients reporting problems taking the drug.
The rate of uninsured Hispanic children fell to a historic low in 2014 with the rate falling to 9.7%, down 2 percentage points below 2013.
In New York State, CVS will make naloxone, a medication that reverses opioid overdose, available without a prescription to customers. Traditionally, naloxone is administered by emergency medical or hospital personnel, but can be administered with minimal training, which CVS pharmacists can now provide when they dispense the drug,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.